Clinical Crossroads in Ophthalmology™ 2021: Best Practices for Treating Complex Cases of Glaucoma, Ocular Surface Disease, and Diabetic Macular Edema (CME Symposium)

Target Audience

This educational activity is intended for ophthalmologists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Use evidence-based treatment strategies for ocular surface disease in patients with other ocular comorbidities
  • Adapt long-term treatment strategies for glaucoma and ocular hypertension according to the latest evidence
  • Develop long-term management plans for patients with diabetic macular edema who are candidates for intravitreal
    corticosteroid treatment
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Course opens: 
11/13/2021
Course expires: 
11/13/2021

Faculty

Joseph F. Panarelli, MD (Chair)
Associate Professor of Ophthalmology
Chief, Division of Glaucoma Services
Glaucoma Fellowship Director
NYU Langone Eye Center
New York, New York

Sunir J. Garg, MD, FACS
Professor of Ophthalmology
Sidney Kimmel Medical College
Thomas Jefferson University
Attending Physician
Retina Service
Wills Eye Hospital
Philadelphia, Pennsylvania

Sonia H. Yoo, MD
Professor of Ophthalmology
Greentree Hickman Chair in Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, Florida

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

Faculty

Sunir J. Garg, MD, is a consultant for Allergan, Apellis Pharmaceuticals, Bausch & Lomb Incorporated, Boehringer Ingelheim International GmbH, Johnson & Johnson Vision Care, Inc, Kanaph Therapeutics, and TopiVert Ltd; and is a contracted researcher for Apellis Pharmaceuticals, Boehringer Ingelheim International GmbH, Genentech, Inc, and Regeneron Pharmaceuticals, Inc.

Joseph F. Panarelli, MD, is a consultant for Aerie Pharmaceuticals, Inc, Allergan, CorneaGen, Glaukos Corporation, New World Medical, Inc, and Santen Inc.

Sonia H. Yoo, MD, is a consultant for Alcon, Dompé US, Inc, and Glaukos Corporation.

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners and Managers

MedEdicus planners and managers have no relevant commercial relationships to disclose.

Accreditation Statement

MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

MedEdicus LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from AbbVie Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or AbbVie Inc.

©2021 MedEdicus LLC. 260

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Please login or register to take this course.

Click Register to proceed to the evaluation and to obtain your certificate.